Natco Pharma Ltd has received approval from the US Food and Drug Administration for its abbreviated new drug application for Lansoprazole delayed release capsules for the prescription market. The drug is indicated for the treatment of gastric (stomach) ulcers. Shipments of the product will commence immediately, the Hyderabad-based company said in a release.
Natco Pharma gets nod for ulcer drug
Hyderabad, Dec. 19:
Track your company
At 65, Dr Marshall Goldsmith is a breath of fresh air. He is known as one of the world’s top CEO coaches and is the author of 34 books including bestsellers such as MOJO and What got... »